Skip to Content

Survey: Sleep volume growth anticipated

Survey: Sleep volume growth anticipated

NEW YORK – Providers expect to see double-digit growth in their sleep patient volume over the next 12 months as flow-generator availability improves, according to the first quarter 2023 HME Sleep and Oxygen Survey from Needham. 

Respondents reported that they have been able to purchase their desired flow generators within required timeframes as follows: Philips, 15.6% (up from 12.1% in Q3 2022); Fisher & Paykel, 25% (up from 9.4% in Q3 2022); and ResMed, 61.4% (up from 39.2% in Q3 2022). 

The eventual re-entry of Philips into the flow generator market appears likely to come at the expense of both smaller competitors and ResMed, with respondents indicating they would return to purchasing 32% of their pre-recall volume from Philips. 

ResMed also looks likely to lose market share in flow generators and masks, with respondents saying they expect the company’s share of flow generator purchases to decline by 12.5% and masks by 2.9%. Respondents expect Philips’ share of flow generator purchases to increase by 17.3% and mask purchases by 0.9%. 

“However, we expect flow generator market share movements to depend on the outcome of Philips’ consent decree and its ability to increase flow generator production as it transitions back to normal production after addressing the recall,” the report states. 

Providers reported that flow generator prices increased by 8.7% in the last 12 months, compared to 10.7% in Q3 2022, likely due to increased supply, says Needham.


To comment on this post, please log in to your account or set up an account now.